Deoxynucleotidyltransferase, terminal (DNTT) Peptide
DNTT
Reactivité: Mammifères
Hôte: Synthetic
BP, WB, IHC
N° du produit ABIN938414
Aperçu rapide pour Deoxynucleotidyltransferase, terminal (DNTT) Peptide (ABIN938414)
Antigène
TdT (DNTT)
(Deoxynucleotidyltransferase, terminal (DNTT))
Origine
Mammifères
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Type de proteíne
- Synthetic
-
Séquence
- FQDLVVFILE KKMGTTRRAF LMELARRKGF RVENELSDSV THIVAENNSG
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of DNTT antibody,
Alternative Names: DNTT control peptide, DNTT antibody Blocking Peptide, Anti-DNTT Blocking Peptide, Deoxynucleotidyltransferase Terminal Blocking Peptide, TDT Blocking Peptide
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- TdT (DNTT) (Deoxynucleotidyltransferase, terminal (DNTT))
-
Sujet
- DNTT is a template-independent DNA polymerase that catalyzes the addition of deoxynucleotides to the 3'-hydroxyl terminus of oligonucleotide primers. In vivo, DNTT is expressed in a restricted population of normal and malignant pre-B and pre-T lymphocytes during early differentiation, where it generates antigen receptor diversity by synthesizing non-germ line elements (N-regions) at the junctions of rearranged Ig heavy chain and T cell receptor geneegments.
-
Poids moléculaire
- 58 kDa
Antigène
-
Vous êtes ici:
